Gut Microbiota Regulate Gut-Lung Axis Inflammatory Responses by Mediating ILC2 Compartmental Migration

Area of Science:

• Immunology
• Microbiology
• Pulmonary Medicine

Background:

• The gut-lung axis links gut microbiota to pulmonary diseases.
• Mechanisms of immune cell trafficking between gut and lung are poorly understood.

Purpose of the Study:

• To investigate how gut microbiota influences immune cell migration to the lung.
• To identify microbial species and molecular pathways involved in gut-lung immune cell trafficking.

Main Methods:

• Utilized integrated microbiota dysbiosis approaches in mouse models.
• Analyzed immune cell migration (ILC2s) from gut to lung.
• Investigated cytokine signaling pathways (IL-33, IL-25) and chemokine interactions (CXCL16, CCL25).

Main Results:

• Gut microbiota directs group 2 innate lymphoid cells (ILC2s) migration from gut to lung.
• Proteobacteria facilitate natural ILC2 migration and induce IL-33 production.
• IL-33-CXCL16 signaling promotes lung ILC2 accumulation, while IL-25-CCL25 signals promote intestinal ILC2 accumulation.
• Distinct roles for lung and intestinal ILC2s in regulating inflammation and host defense.

Conclusions:

• Proteobacteria in the gut microbiota modulate ILC2 migration to the lung via IL-33.
• This gut-lung axis communication is crucial for host defense against infection.
• Findings suggest novel therapeutic strategies targeting gut microbiota for infectious diseases.